Caribou Biosciences, Inc. Profile Avatar - Palmy Investing

Caribou Biosciences, Inc.

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead…

Biotechnology
US, Berkeley [HQ]
Supply · Problems · Premarket · Compliance

Supply Analysis

End of CRBU's Analysis
CIK: 1619856 CUSIP: 142038108 ISIN: US1420381089 LEI: - UEI: -
Secondary Listings
CRBU has no secondary listings inside our databases.